Sommario

• • ·Angioplasty, inflammation, and antiplatelet agents

    Pagina :563-566

    David J. Moliterno, Marc S. Penn

    
• • ·Endothelium-independent coronary microvascular function: All vessels are not created equally

    Pagina :567-568

    David Hasdai

    
• • ·Lessons from the implantable atrial defibrillator

    Pagina :569-570

    Derick M. Todd, Raymond Yee

    
• • ·Assessing quality and outcomes for percutaneous coronary intervention: Choosing statistical models, outcomes, time periods, and patient populations

    Pagina :571-574

    Edward L. Hannan, Chuntao Wu

    
• • ·Heart failure with preserved systolic function after myocardial infarction: A growing burden?

    Pagina :575-578

    Jalal K. Ghali

    
• • ·Coronary calcium: Is racial profiling necessary?

    Pagina :579-581

    Rita Redberg

    
• • ·Left atrial thrombus, transient ischemic attack, and atrial fibrillation: Does left atrial thrombus predict? Does absence protect?

    Pagina :582-585

    Richard G. Sheahan

    
• • ·Anticoagulation in acute cardiac care in patients with chronic kidney disease

    Pagina :586-594

    Donal Reddan, Lynda A. Szczech, Susan O'Shea, Robert M. Califf

    Riassunto Riassunto
• • ·The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable?

    Pagina :595-601

    Gregory P. Gerschutz, Deepak L. Bhatt

    Riassunto Riassunto
• • ·Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study

    Pagina :602-613

    Elizabeth R. Hauser, Vincent Mooser, David C. Crossman, Jonathan L. Haines, Christopher H. Jones, Bernhard R. Winkelmann, Silke Schmidt, William K. Scott, Allen D. Roses, Margaret A. Pericak-Vance, Christopher B. Granger, William E. Kraus

    Riassunto Riassunto
• • ·Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

    Pagina :614-621

    Franz-Xaver Kleber, Christian Witt, Günter Vogel, Klaus Koppenhagen, Ulrike Schomaker, Curt Werner Flosbach, THE-PRINCE Study Group

    Riassunto Riassunto
• • ·Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study

    Pagina :622-627

    Gad Cotter, Christopher P. Cannon, Carolyn H. McCabe, Yoav Michowitz, Edo Kaluski, Andrew Charlesworth, Olga Milo, Jane Bentley, Alex Blatt, Rikardo Krakover, Reuven Zimlichman, Leonardo Reisin, Alon Marmor, Basil Lewis, Zvi Vered, Avi Caspi, Eugene Braunwald, OPUS-TIMI 16 Investigators

    Riassunto Riassunto
• • ·Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice

    Pagina :628-635

    Oscar C. Marroquin, Richard Holubkov, Daniel Edmundowicz, Cheryl Rickens, Gerald Pohost, Steven Buchthal, Carl J. Pepine, George Sopko, Robert C. Sembrat, Carolyn Cidis Meltzer, Steven E. Reis

    Riassunto Riassunto
• • ·Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy

    Pagina :636-642

    Victor L. Serebruany, Alex I. Malinin, Kevin P. Callahan, Azan Binbrek, Frans Van de Werf, John H. Alexander, Christopher B. Granger, Paul A. Gurbel

    Riassunto Riassunto
• • ·Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study

    Pagina :643-651

    Wendy Hague, Peta Forder, John Simes, David Hunt, Andrew Tonkin, LIPID Investigators

    Riassunto Riassunto
• • ·Smoking and health outcomes after percutaneous coronary intervention

    Pagina :652-657

    C.Keith Haddock, Walker S.C. Poston, Jennifer E. Taylor, Mark Conard, John Spertus

    Riassunto Riassunto
• • ·Adjusting for patient differences in predicting hospital mortality for percutaneous coronary interventions in the Clinical Outcomes Assessment Program

    Pagina :658-664

    Charles Maynard, J.Richard Goss, David J. Malenka, Mark Reisman, Clinical Outcomes Assessment Program

    Riassunto Riassunto
• • ·Use patterns of low-molecular weight heparin and the impact on length of stay in patients hospitalized for atrial fibrillation

    Pagina :665-669

    Michael H. Kim, Benigno F. Decena, David Bruckman, Kim A. Eagle

    Riassunto Riassunto
• • ·What characterizes episodes of atrial fibrillation requiring cardioversion? Experience from patients with an implantable atrial cardioverter

    Pagina :670-675

    Viveka Frykman, Gregory M. Ayers, Börje Darpö, Mårten Rosenqvist

    Riassunto Riassunto
• • ·Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation

    Pagina :676-682

    Marcus F. Stoddard, Pradeep Singh, Buddhadeb Dawn, Rita A. Longaker

    Riassunto Riassunto
• • ·Limitations of current risk-adjustment models in the era of coronary stenting

    Pagina :683-692

    Jorge R. Kizer, Jesse A. Berlin, Warren K. Laskey, J.Sanford Schwartz, William H. Sauer, Ronald J. Krone, Stephen E. Kimmel

    Riassunto Riassunto
• • ·Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism

    Pagina :693-699

    Andreas W. Bonz, Björn Lengenfelder, Martina Jacobs, Jörg Strotmann, Stefanie Held, Georg Ertl, Wolfram Voelker

    Riassunto Riassunto
• • ·Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty

    Pagina :700-707

    Carlo Briguori, Cristiano Sarais, Paolo Pagnotta, Flavio Airoldi, Francesco Liistro, Fabio Sgura, Vassilis Spanos, Mauro Carlino, Matteo Montorfano, Carlo Di Mario, Antonio Colombo

    Riassunto Riassunto
• • ·Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention

    Pagina :708-715

    Bruce R. Brodie, Thomas D. Stuckey, Denise B. Muncy, Charles J. Hansen, Thomas C. Wall, Mark Pulsipher, Navin Gupta

    Riassunto Riassunto
• • ·Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: Results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P²C² HIV) multicenter study

    Pagina :716-723

    Shannon M. Rivenes, Steven D. Colan, Kirk A. Easley, Samuel Kaplan, Kathy J. Jenkins, Mohammed N. Khan, Wyman W. Lai, Steven E. Lipshultz, Douglas S. Moodie, Thomas J. Starc, George Sopko, Weihong Zhang, J.Timothy Bricker, Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

    Riassunto Riassunto
• • ·Coronary artery calcification in black women and white women

    Pagina :724-729

    Charanjit Khurana, Christina G. Rosenbaum, Barbara V. Howard, Lucile L. Adams-Campbell, Robert C. Detrano, Afifa Klouj, Judith Hsia

    Riassunto Riassunto
• • ·Interatrial septal mobility predicts larger shunts across patent foramen ovales: An analysis with transmitral Doppler scanning

    Pagina :730-736

    Ervin R. Fox, Michael H. Picard, Chi-Ming Chow, Robert A. Levine, Lee Schwamm, Andrew J. Kerr

    Riassunto Riassunto
• • ·Nickel release after implantation of the Amplatzer occluder

    Pagina :737-741

    Marcus W. Ries, Christoph Kampmann, Hans-Jürgen Rupprecht, Gudrun Hintereder, Gerd Hafner, Jürgen Meyer

    Riassunto Riassunto
• • ·Heart failure after myocardial infarction: Prevalence of preserved left ventricular systolic function in the community

    Pagina :742-748

    Jens P. Hellermann, Steven J. Jacobsen, Guy S. Reeder, Francisco Lopez-Jimenez, Susan A. Weston, Véronique L. Roger

    Riassunto Riassunto
• • ·Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: The Tenax versus Nir Stent Study's long-term outcome

    Pagina :E17

    Martin Unverdorben, Babett Sippel, Ralf Degenhardt, Katherine Sattler, Roland Fries, Bernd Abt, Eberhard Wagner, Henning Koehler, Gabriele Daemgen, Manfred Scholz, Hassan Ibrahim, Karl-Heinz Tews, Benno Hennen, Heiner K. Berthold, Christian Vallbracht

    Riassunto Riassunto